Subsys Opioid Pain Relief Mouth Spray

Linked to Serious Opioid Addiction and Death

Source: Subsys

Subsys, a fentanyl-based pain relief mouth spray, was developed by Insys Therapeutics and approved by the FDA to treat breakthrough cancer pain.

The drug delivers a painkiller mist 100 times more powerful than morphine. When used as directed, Subsys offers much-needed relief for cancer patients during the sudden, intense pain flare-ups that can’t be addressed with other medications.

Unfortunately, the highly addictive drug can have severe consequences when it’s prescribed to non-cancer patients for off-label use.

Some individuals suffering from chronic pain or other injuries and conditions received Subsys.

Complications from Subsys

Many of these non-cancer patients suffered serious complications including:

  • Opioid addiction
  • Overdoses
  • Death

Concerns about the dangers of off-label use of Subsys and the practices Insys used to market and sell the drug have come to light as the country battles a devastating opioid epidemic.

Elk & Elk is currently investigating claims that off-label use of Subsys for non-cancer patients was linked to serious complications including opioid addiction and death.

Contact us today for a free consultation if you or a loved one were prescribed Subsys opioid pain relief mouth spray without a cancer diagnosis.